Pangilan, Hazele Luck B.

HRN: 03-43-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2023
CEFUROXIME 1.5GM (VIAL)
12/07/2023
12/14/2023
IV
1.5gram
Q8hr
Surgical Prophylaxis
Checking Final Appropriateness 
12/07/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/07/2023
12/08/2023
IV
900
Q8
Pelvic Lap; Ruptured Ectopic Preg
Checking Final Appropriateness 
12/07/2023
CEFUROXIME 1.5GM (VIAL)
12/07/2023
12/08/2023
IV
1.5
Q8
Pelvic Lap
Checking Final Appropriateness 
12/08/2023
CEFUROXIME 500MG (TAB)
12/08/2023
12/14/2023
PO
1 Cap
BID
Prophylactic Post Pelvic Laparotomy
Checking Final Appropriateness 
12/08/2023
DOXYCYCLINE 100MG (CAP)
12/08/2023
12/14/2023
PO
1 Cap
BID
Prophylaxis Post Pelvic Laparotomy
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: